Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T20:28:27.629Z.
Calculation as of: 2026-10-06T20:28:27.629Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 17ab06c48f69affb221de34704d4dabd8e8a0a72c6427d5ea23a05e764636018
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2024-02-08.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
15.28x
EV/EBITDA RATIO AVG 3Y
20.80x
EV/EBITDA RATIO AVG 5Y
24.55x
EV/EBITDA RATIO AVG 10Y
21.84x
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Vanda Pharmaceuticals Inc.
Market Cap
$271.81M
EV/EBITDA Ratio
N/A
TTM Avg
15.28x
3Y Avg
20.80x
5Y Avg
24.55x
Market Cap
$270.80M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.59M
EV/EBITDA Ratio
N/A
TTM Avg
71.43x
3Y Avg
71.43x
5Y Avg
71.43x
Market Cap
$265.78M
EV/EBITDA Ratio
N/A
TTM Avg
10.21x
3Y Avg
10.21x
5Y Avg
10.68x
Market Cap
$280.37M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$262.92M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$281.54M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc. (VNDA) | $271.81M | N/A | 15.28x | 20.80x | 24.55x |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $270.80M | N/A | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE)vs › | $266.92M | N/A | N/A | N/A | N/A |
| SAB Biotherapeutics, Inc. (SABS)vs › | $266.59M | N/A | 71.43x | 71.43x | 71.43x |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $265.78M | N/A | 10.21x | 10.21x | 10.68x |
| Scribe Therapeutics Inc. (SCTX)vs › | $264.25M | N/A | N/A | N/A | N/A |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $280.37M | N/A | N/A | N/A | N/A |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | N/A | N/A | N/A | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.54M | N/A | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2024-02-08 | 26.72x |
| 2024-02-07 | 15.88x |
| 2024-02-06 | 18.15x |
| 2024-02-05 | 11.60x |
| 2024-02-02 | 15.63x |
| 2024-02-01 | 18.15x |
| 2024-01-31 | 14.87x |
| 2024-01-30 | 16.13x |
| 2024-01-29 | 19.91x |
| 2024-01-26 | 18.65x |
| 2024-01-25 | 19.66x |
| 2024-01-24 | 16.64x |
| 2024-01-23 | 17.65x |
| 2024-01-22 | 19.66x |
| 2024-01-19 | 16.39x |
| 2024-01-18 | 17.14x |
| 2024-01-17 | 18.91x |
| 2024-01-16 | 18.91x |
| 2024-01-12 | 21.17x |
| 2024-01-11 | 22.94x |
| 2024-01-10 | 23.44x |
| 2024-01-09 | 29.24x |
| 2024-01-08 | 31.50x |
| 2024-01-05 | 29.74x |
| 2024-01-04 | 30.75x |
| 2024-01-03 | 32.01x |
| 2024-01-02 | 38.05x |
| 2023-12-29 | 30.50x |
| 2023-12-28 | 31.50x |
| 2023-12-27 | 32.51x |
| 2023-12-26 | 26.21x |
| 2023-12-22 | 24.20x |
| 2023-12-21 | 21.17x |
| 2023-12-20 | 19.91x |
| 2023-12-19 | 24.45x |
| 2023-12-18 | 21.43x |
| 2023-12-15 | 21.93x |
| 2023-12-14 | 21.17x |
| 2023-12-13 | 23.94x |
| 2023-12-12 | 20.17x |
| 2023-12-11 | 18.15x |
| 2023-12-08 | 18.91x |
| 2023-12-07 | 24.20x |
| 2023-12-06 | 25.96x |
| 2023-12-05 | 23.94x |
| 2023-12-04 | 21.17x |
| 2023-12-01 | 22.43x |
| 2023-11-30 | 17.90x |
| 2023-11-29 | 15.88x |
| 2023-11-28 | 13.61x |
| 2023-11-27 | 13.87x |
| 2023-11-24 | 13.87x |
| 2023-11-22 | 12.61x |
| 2023-11-21 | 11.10x |
| 2023-11-20 | 14.37x |
| 2023-11-17 | 13.61x |
| 2023-11-16 | 9.33x |
| 2023-11-15 | 13.61x |
| 2023-11-14 | 13.61x |
| 2023-11-13 | 10.09x |
| 2023-11-10 | 10.09x |
| 2023-11-09 | 4.46x |
| 2023-11-08 | 8.90x |
| 2023-11-07 | 9.37x |
| 2023-11-06 | 9.51x |
| 2023-11-03 | 9.79x |
| 2023-11-02 | 9.56x |
| 2023-11-01 | 9.09x |
| 2023-10-31 | 9.14x |
| 2023-10-30 | 8.95x |
| 2023-10-27 | 8.06x |
| 2023-10-26 | 9.19x |
| 2023-10-25 | 8.67x |
| 2023-10-24 | 8.39x |
| 2023-10-23 | 8.48x |
| 2023-10-20 | 8.95x |
| 2023-10-19 | 8.81x |
| 2023-10-18 | 9.61x |
| 2023-10-17 | 9.65x |
| 2023-10-16 | 9.28x |
| 2023-10-13 | 8.53x |
| 2023-10-12 | 8.95x |
| 2023-10-11 | 9.79x |
| 2023-10-10 | 9.89x |
| 2023-10-09 | 9.65x |
| 2023-10-06 | 10.07x |
| 2023-10-05 | 9.51x |
| 2023-10-04 | 8.76x |
| 2023-10-03 | 7.97x |
| 2023-10-02 | 8.16x |
| 2023-09-29 | 8.86x |
| 2023-09-28 | 9.04x |
| 2023-09-27 | 10.40x |
| 2023-09-26 | 9.89x |
| 2023-09-25 | 9.47x |
| 2023-09-22 | 9.75x |
| 2023-09-21 | 9.51x |
| 2023-09-20 | 8.67x |
| 2023-09-19 | 9.19x |
| 2023-09-18 | 9.51x |
| 2023-09-15 | 10.64x |
| 2023-09-14 | 10.87x |
| 2023-09-13 | 10.87x |
| 2023-09-12 | 10.45x |
| 2023-09-11 | 10.59x |
| 2023-09-08 | 10.26x |
| 2023-09-07 | 10.03x |
| 2023-09-06 | 9.19x |
| 2023-09-05 | 9.61x |
| 2023-09-01 | 12.56x |
| 2023-08-31 | 12.93x |
| 2023-08-30 | 13.68x |
| 2023-08-29 | 14.29x |
| 2023-08-28 | 14.62x |
| 2023-08-25 | 14.76x |
| 2023-08-24 | 15.37x |
| 2023-08-23 | 16.21x |
| 2023-08-22 | 16.44x |
| 2023-08-21 | 16.44x |
| 2023-08-18 | 16.02x |
| 2023-08-17 | 15.98x |
| 2023-08-16 | 15.69x |
| 2023-08-15 | 16.58x |
| 2023-08-14 | 16.91x |
| 2023-08-11 | 16.91x |
| 2023-08-10 | 16.82x |
| 2023-08-09 | 16.86x |
| 2023-08-08 | 17.05x |
| 2023-08-07 | 15.88x |
| 2023-08-04 | 16.07x |
| 2023-08-03 | 15.04x |
| 2023-08-02 | 14.38x |
| 2023-08-01 | 15.04x |
| 2023-07-31 | 15.69x |
| 2023-07-27 | 1.46x |
| 2023-07-26 | 1.62x |
| 2023-07-25 | 1.28x |
| 2023-07-24 | 1.37x |
| 2023-07-21 | 1.68x |
| 2023-07-20 | 1.28x |
| 2023-07-19 | 1.13x |
| 2023-07-18 | 1.22x |
| 2023-07-17 | 0.24x |
| 2023-07-14 | 0.14x |
| 2023-07-13 | 0.14x |
| 2023-07-12 | 0.79x |
| 2023-07-11 | 0.63x |
| 2023-07-10 | 1.37x |
| 2023-07-07 | 1.68x |
| 2023-07-06 | 1.80x |
| 2023-07-05 | 1.52x |
| 2023-07-03 | 1.37x |
| 2023-06-30 | 1.86x |
| 2023-06-29 | 2.08x |
| 2023-06-28 | 1.25x |
| 2023-06-27 | 1.59x |
| 2023-06-26 | 1.95x |
| 2023-06-23 | 1.65x |
| 2023-06-22 | 1.37x |
| 2023-06-21 | 0.82x |
| 2023-06-20 | 1.22x |
| 2023-06-16 | 1.09x |
| 2023-06-15 | 1.09x |
| 2023-06-14 | 0.88x |
| 2023-06-13 | 1.71x |
| 2023-06-12 | 1.71x |
| 2023-06-09 | 1.59x |
| 2023-06-08 | 1.59x |
| 2023-06-07 | 1.46x |
| 2023-06-06 | 0.82x |
| 2023-06-05 | 0.36x |
| 2023-06-02 | 0.24x |
| 2023-05-26 | 0.39x |
| 2023-05-25 | 0.02x |
| 2023-05-24 | 0.39x |
| 2023-05-23 | 0.97x |
| 2023-05-22 | 0.67x |
| 2023-05-19 | 0.67x |
| 2023-05-18 | 0.39x |
| 2023-05-17 | 0.70x |
| 2023-05-16 | 0.51x |
| 2023-05-15 | 1.03x |
| 2023-05-12 | 0.91x |
| 2023-05-11 | 0.67x |
| 2023-05-10 | 2.45x |
| 2023-05-09 | 2.58x |
| 2023-05-08 | 2.91x |
| 2023-05-05 | 2.97x |
| 2023-05-04 | 2.72x |
| 2023-05-03 | 26.65x |
| 2023-05-02 | 26.84x |
| 2023-05-01 | 26.91x |
| 2023-04-28 | 25.08x |
| 2023-04-27 | 25.46x |
| 2023-04-26 | 26.02x |
| 2023-04-25 | 25.83x |
| 2023-04-24 | 25.83x |
| 2023-04-21 | 26.40x |
| 2023-04-20 | 25.39x |
| 2023-04-19 | 25.96x |
| 2023-04-18 | 25.65x |
| 2023-04-17 | 27.60x |
| 2023-04-14 | 27.10x |
| 2023-04-13 | 30.13x |
| 2023-04-12 | 29.12x |
| 2023-04-11 | 29.24x |
| 2023-04-10 | 28.86x |
| 2023-04-06 | 29.68x |
| 2023-04-05 | 28.93x |
| 2023-04-04 | 28.61x |
| 2023-04-03 | 29.49x |
| 2023-03-31 | 29.18x |
| 2023-03-30 | 28.67x |
| 2023-03-29 | 29.75x |
| 2023-03-28 | 29.18x |
| 2023-03-27 | 29.43x |
| 2023-03-24 | 28.93x |
| 2023-03-23 | 28.11x |
| 2023-03-22 | 27.73x |
| 2023-03-21 | 28.67x |
| 2023-03-20 | 27.98x |
| 2023-03-17 | 27.48x |
| 2023-03-16 | 26.53x |
| 2023-03-15 | 26.65x |
| 2023-03-14 | 26.21x |
| 2023-03-13 | 25.52x |
| 2023-03-10 | 25.46x |
| 2023-03-09 | 25.33x |
| 2023-03-08 | 25.46x |
| 2023-03-07 | 25.96x |
| 2023-03-06 | 26.28x |
| 2023-03-03 | 26.53x |
| 2023-03-02 | 26.15x |
| 2023-03-01 | 27.03x |
| 2023-02-28 | 26.97x |
| 2023-02-27 | 27.54x |
| 2023-02-24 | 27.16x |
| 2023-02-23 | 28.49x |
| 2023-02-22 | 28.86x |
| 2023-02-21 | 28.74x |
| 2023-02-17 | 30.88x |
| 2023-02-16 | 30.82x |
| 2023-02-15 | 30.44x |
| 2023-02-14 | 30.76x |
| 2023-02-13 | 31.89x |
| 2023-02-10 | 32.21x |
| 2023-02-09 | 33.52x |
| 2023-02-08 | 33.21x |
| 2023-02-07 | 35.31x |
| 2023-02-06 | 35.21x |
| 2023-02-03 | 35.77x |
| 2023-02-02 | 36.70x |
| 2023-02-01 | 35.88x |
| 2023-01-31 | 35.93x |
| 2023-01-30 | 35.52x |
| 2023-01-27 | 35.77x |
| 2023-01-26 | 35.98x |
| 2023-01-25 | 35.88x |
| 2023-01-24 | 35.83x |
| 2023-01-23 | 35.83x |
Showing the most recent 260 of 1,868 data points. The chart above shows the full history.
